In tumor‐associated sarcopenia, such as in pancreatic ductal adenocarcinoma and hepatocellular carcinoma, tumor‐infiltrating CD8+ T cells are strongly associated with sarcopenia and poor clinical outcomes [340, 341]. The gene discussed is CD8A; the disease is sarcopenia.